bioRxivImmunology
Poly dispersed acid-functionalized single walled carbon nanotubes target activated T and B cells to suppress GVHD in mouse model
Abstract
Graft versus host disease (GVHD) results from hyper-activation of transplanted lymphocytes against the host antigens. Bone marrow transplantation in humans as well as some cases of blood transfusion and organ transplantation are associated with a strong GVH reaction resulting in GVHD that in many cases may be fatal. We had previously shown that poly-dispersed acid-functionalized single-walled carbon nanotubes (AF-SWCNTs) specifically target activated T and B lymphocytes and kill them. In the present study, efficacy of AF-SWCNTs to suppress the GVH reaction was tested in the mouse model. Acute GVHD was induced in mice by administering intravenously 30 or 60 million spleen cells from a parental strain (C57bl/6 mouse, MHC haplotype H-2b) to host (C57bl/6 x Balb/c) F1 mice (MHC haplotype H-2b/d) and waiting for 8-10 days. Chronic GVHD was similarly induced by administration of 30 million parent spleen cells to F1 mice and waiting for a period of 60 days. Our results demonstrate a marked decline in splenomegaly and recovery of spleen T (both CD4 and CD8) and B cells in GVHD mice treated with AF-SWCNTs. AF-SWCNTs treatment also limited T and B cell proliferation by restricting S-phage of cell cycle. Generation of anti-host cytotoxic T cells (CTLs) was also markedly suppressed by AF-SWCNT treatment of acute GVHD mice, and a significant reduction in the generation of anti-host antibodies could also be demonstrated. Taken together, our results suggest that the AF-SWCNTs can be considered as a potential therapeutic agent for treating GVHD.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Role of N-acetylcysteine Amide in Acute Graft-versus-host Disease Mouse Model
Rui He, Wenyi Zheng, … Moustapha Hassan·bioRxiv·Apr 7, 2025
- Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model
Kouta Niizuma, Alyssa H Chang, … Yusuke Nakauchi·Blood AdvancesPeer-reviewed·Jul 21, 2026
- Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT
Duneia McManus, Sabrina N. Copsel, … Robert B. Levy·BloodPeer-reviewed·Aug 1, 2025
- TCF-1 in CD4 T cells regulates GVHD severity and persistence
R. Harris, M. Mammadli, … M. Karimi·bioRxiv·Mar 22, 2021
- Wnt/β-catenin regulates alloreactive T cells for the treatment of hematological malignancies
M. Mammadli, R. Harris, … M. Karimi·bioRxiv·Apr 12, 2021
- Donor monocyte-derived macrophages promote human acute graft versus host disease
L. Jardine, U. Cytlak, … M. Collin·bioRxiv·Sep 30, 2019